Figure 5From: The Chronobra identifies prevailing mammary vascularity as a candidate variable in breast cancer post-operative outcome prediction Individual example of daily breast vascularity, salivary progesterone and plasma oestradiol over one menstrual cycle for a patient, age 36.9 y at Chronobra study, that developed breast cancer 20 y later at age 56.5 y and died 2.5 y later from the disease at age 59.1 y. Back to article page